RxIndia
Loading clinical data...
Loading clinical data...
Authoritative Clinical Reference
Therapeutic Class: Antiallergic agents
Subclass: Leukotriene receptor antagonist + Second-generation antihistamine
Speciality: Allergy & Immunology
Schedule (India): Schedule H
Route: Oral
Formulations:
- Tablet: Montelukast 10 mg + Levocetirizine 5 mg
- Paediatric Tablet:
• Montelukast 4 mg + Levocetirizine 2.5 mg
• Montelukast 5 mg + Levocetirizine 2.5 mg
- Syrup/Oral Suspension: 4 mg + 2.5 mg per 5 mL
Adult Indications:
1. Allergic Rhinitis (Seasonal and Perennial)
- Dose: 1 tablet once daily (evening)
- Duration: 2–4 weeks (seasonal) or long-term (perennial)
- Maximum Dose: 1 tablet per day
2. Asthma with Allergic Rhinitis (Adjunct)
- Used as add-on therapy
- Not a substitute for inhaled corticosteroids
- Reassess every 4–6 weeks
Paediatric Dosing:
- 2–5 years:
Syrup: 4 mg + 2.5 mg (5 mL) once daily (evening)
- 6–14 years:
Tablet/Syrup: 5 mg + 2.5 mg once daily (evening)
- ≥15 years:
Adult dose (10 mg + 5 mg once daily)
Contraindications:
- Hypersensitivity to Montelukast or Levocetirizine
- Severe renal impairment (eGFR <30 mL/min)
- Severe hepatic impairment
- Children below 2 years
Common Side Effects:
- Drowsiness
- Headache
- Dry mouth
- Nausea
- Fatigue
Serious Side Effects:
- Neuropsychiatric symptoms (anxiety, depression, suicidal thoughts)
- Angioedema
- Anaphylaxis
- Hepatotoxicity
Brands in India:
- Montair LC
- Montek LC
- LC Montus
- Odimont LC
- Levocet M
Price Range (INR):
- Tablet (10 mg + 5 mg): ₹6–14
- Paediatric Tablet (5 mg + 2.5 mg): ₹5–10
- Syrup (60 mL): ₹35–70
This platform is designed strictly for healthcare professionals. Data provided is synthesized from authoritative pharmacological sources and clinical registries. Do not use for consumer medical decisions. Always verify critical dosing and contraindications with official institutional protocols and peer-reviewed journals.
Help us improve our clinical database for the medical community.